These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35022323)
1. Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy. Guix I; Liu Q; Pujana MA; Ha P; Piulats J; Linares I; Guedea F; Mao JH; Lazar A; Chapman J; Yom SS; Ashworth A; Barcellos-Hoff MH Clin Cancer Res; 2022 Apr; 28(7):1372-1382. PubMed ID: 35022323 [TBL] [Abstract][Full Text] [Related]
2. Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types. Liu Q; Palomero L; Moore J; Guix I; Espín R; Aytés A; Mao JH; Paulovich AG; Whiteaker JR; Ivey RG; Iliakis G; Luo D; Chalmers AJ; Murnane J; Pujana MA; Barcellos-Hoff MH Sci Transl Med; 2021 Feb; 13(580):. PubMed ID: 33568520 [TBL] [Abstract][Full Text] [Related]
3. Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining. Liu Q; Ma L; Jones T; Palomero L; Pujana MA; Martinez-Ruiz H; Ha PK; Murnane J; Cuartas I; Seoane J; Baumann M; Linge A; Barcellos-Hoff MH Clin Cancer Res; 2018 Dec; 24(23):6001-6014. PubMed ID: 30087144 [TBL] [Abstract][Full Text] [Related]
4. DNA damage response factors from diverse pathways, including DNA crosslink repair, mediate alternative end joining. Howard SM; Yanez DA; Stark JM PLoS Genet; 2015 Jan; 11(1):e1004943. PubMed ID: 25629353 [TBL] [Abstract][Full Text] [Related]
5. Lack of TGFβ signaling competency predicts immune poor cancer conversion to immune rich and response to checkpoint blockade. Moore J; Gkantalis J; Guix I; Chou W; Yuen K; Lazar AA; Spitzer M; Combes AJ; Barcellos-Hoff MH bioRxiv; 2024 May; ():. PubMed ID: 38496519 [TBL] [Abstract][Full Text] [Related]
6. Regulation of DNA repair in the absence of classical non-homologous end joining. Kang YJ; Yan CT DNA Repair (Amst); 2018 Aug; 68():34-40. PubMed ID: 29929045 [TBL] [Abstract][Full Text] [Related]
7. Alternative end-joining repair pathways are the ultimate backup for abrogated classical non-homologous end-joining and homologous recombination repair: Implications for the formation of chromosome translocations. Iliakis G; Murmann T; Soni A Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():166-75. PubMed ID: 26520387 [TBL] [Abstract][Full Text] [Related]
8. Nucleoside Analogs Radiosensitize G0 Cells by Activating DNA End Resection and Alternative End-Joining. Magin S; Meher PK; Iliakis G Radiat Res; 2021 May; 195(5):412-426. PubMed ID: 33755161 [TBL] [Abstract][Full Text] [Related]
9. Detection of Alternative End-Joining in HNSC Cell Lines Using DNA Double-Strand Break Reporter Assays. Zuo N; Ma L; Hu W; Deng Y; Wei L; Liu Q Bio Protoc; 2022 Sep; 12(17):. PubMed ID: 36213110 [TBL] [Abstract][Full Text] [Related]
10. Recovery of Alternative End-Joining Repair Products From Drosophila Embryos. Hanscom T; Khodaverdian VY; McVey M Methods Enzymol; 2018; 601():91-110. PubMed ID: 29523244 [TBL] [Abstract][Full Text] [Related]
11. Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells. Dickreuter E; Eke I; Krause M; Borgmann K; van Vugt MA; Cordes N Oncogene; 2016 Mar; 35(11):1353-62. PubMed ID: 26073085 [TBL] [Abstract][Full Text] [Related]
12. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress. Chroma K; Mistrik M; Moudry P; Gursky J; Liptay M; Strauss R; Skrott Z; Vrtel R; Bartkova J; Kramara J; Bartek J Oncogene; 2017 Apr; 36(17):2405-2422. PubMed ID: 27841863 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus 16 promotes microhomology-mediated end-joining. Leeman JE; Li Y; Bell A; Hussain SS; Majumdar R; Rong-Mullins X; Blecua P; Damerla R; Narang H; Ravindran PT; Lee NY; Riaz N; Powell SN; Higginson DS Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21573-21579. PubMed ID: 31591214 [TBL] [Abstract][Full Text] [Related]
15. Disruption of Chromatin Dynamics by Hypotonic Stress Suppresses HR and Shifts DSB Processing to Error-Prone SSA. Krieger LM; Mladenov E; Soni A; Demond M; Stuschke M; Iliakis G Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681628 [TBL] [Abstract][Full Text] [Related]
16. The nuclear structural protein NuMA is a negative regulator of 53BP1 in DNA double-strand break repair. Salvador Moreno N; Liu J; Haas KM; Parker LL; Chakraborty C; Kron SJ; Hodges K; Miller LD; Langefeld C; Robinson PJ; Lelièvre SA; Vidi PA Nucleic Acids Res; 2019 Apr; 47(6):2703-2715. PubMed ID: 30812030 [TBL] [Abstract][Full Text] [Related]
17. A functional ex vivo assay to detect PARP1-EJ repair and radiosensitization by PARP-inhibitor in prostate cancer. Köcher S; Beyer B; Lange T; Nordquist L; Volquardsen J; Burdak-Rothkamm S; Schlomm T; Petersen C; Rothkamm K; Mansour WY Int J Cancer; 2019 Apr; 144(7):1685-1696. PubMed ID: 30478958 [TBL] [Abstract][Full Text] [Related]
18. Role for Artemis nuclease in the repair of radiation-induced DNA double strand breaks by alternative end joining. Moscariello M; Wieloch R; Kurosawa A; Li F; Adachi N; Mladenov E; Iliakis G DNA Repair (Amst); 2015 Jul; 31():29-40. PubMed ID: 25973742 [TBL] [Abstract][Full Text] [Related]
19. Misrepair in Context: TGFβ Regulation of DNA Repair. Liu Q; Lopez K; Murnane J; Humphrey T; Barcellos-Hoff MH Front Oncol; 2019; 9():799. PubMed ID: 31552165 [TBL] [Abstract][Full Text] [Related]
20. Combined EGFR1 and PARP1 Inhibition Enhances the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Models. Frederick BA; Gupta R; Atilano-Roque A; Su TT; Raben D Radiat Res; 2020 Nov; 194(5):519-531. PubMed ID: 32936912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]